Navigation Links
Perampanel for epilepsy: No proof of added benefit
Date:1/30/2013

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In an early benefit assessment according to the German Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether perampanel offers an added benefit over the previous standard therapy. However, no such added benefit can be derived from the dossier, because the manufacturer failed to present any relevant data in it for the comparison with the drugs lamotrigine or topiramate.

Lamotrigine and topiramate as appropriate comparator therapy

Fits that affect only a small part of the brain are called "focal" or "partial seizures". In this type of fit, the muscle twitches and spasms remain limited to isolated parts of the body. They may, however, spread over the entire body and this process is then called a "secondary generalization". Perampanel is approved as add-on therapy for the treatment of partial seizures with or without secondary generalization in people aged 12 years and older.

When the Federal Joint Committee (G-BA) specified the appropriate comparator therapy, it distinguished between two treatment situations: if the first-line (basic) anti-epileptic treatment does not contain lamotrigine, perampanel as add-on therapy should be compared with lamotrigine as add-on therapy. If, on the other hand, lamotrigine is already part of the basic treatment, then perampanel as add-on therapy should be compared with topiramate as add-on therapy.

Topiramate not considered in the dossier

However, in its dossier, the pharmaceutical company deviated from this specification of the G-BA and considered only lamotrigine. In those cases where lamotrigine was already contained in the basic treatment, the manufacturer stated that a comparison with top
'/>"/>

Contact: Anna-Sabine Ernst
presse@iqwig.de
49-221-356-85153
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2

Related medicine news :

1. No Proof That Gum Disease Causes Heart Disease, Experts Say
2. More Proof That Healthy Habits Fight Disease
3. More Proof Cranberry Juice Thwarts Infection
4. No proof that patients lose weight after joint replacement surgery
5. Vandetanib in thyroid cancer: No proof of added benefit
6. No Proof That Doping With EPO Gives Athletes an Edge: Review
7. Corporate Whistle Blower Center Now Urges Physicians, Medical Device or Drug Insiders With Proof A Company Knowingly Sold A Bad Product to Become a Whistleblower
8. Corporate Whistle Blower Center Now Urges Physicians to Become a Whistleblower if They Have Proof a Medical Device or a Drug Product was Defective-and it was Sold Anyway
9. Pesticides and Parkinsons: UCLA researchers uncover further proof of a link
10. Corporate Whistle Blower Center Now Urges Physicians Medical Device and Drug Industry Insiders To Step Up-If They Have Proof Of Serious Wrongdoing or Overbilling
11. No Proof Drugs Ease Kids Migraines: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... 28, 2015 , ... The Denver Foundation and Blair-Caldwell African ... Exhibited,” a photographic and narrative exploration of African American giving, which runs August ... , Denver is one of only ten cities to host “The Soul of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Representatives with CareMed Urgent ... full support of National Immunization Awareness Month, which is the month of August. ... serious illnesses like the flu, measles, and pneumonia, adults need to get their ...
(Date:7/28/2015)... FAIRFAX, Virginia (PRWEB) , ... July 28, 2015 , ... ... in the Washington, D.C. technology community for over 20 years, has selected Lisa Dezzutti, ... for the upcoming year. , “I am excited to serve this organization that empowers ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Egg freezing ... the procedure to help ensure future fertility. As Dr. Michael Kettel explained ... freezing is an option that wasn’t available for previous generations who had to make ...
(Date:7/28/2015)... ... ... to WFTV on July 15th heroin overdose rates have increased by 270 ... statistic Orlando suffers at least one death weekly as a direct result of a ... officials are struggling to keep apace with its distribution. Officers rely on inside information ...
Breaking Medicine News(10 mins):Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3
... , , Covers Europe, Middle East and ... , Includes Licensing Option and Development Funding for NGX-1998 ... June 22 NeurogesX, Inc. (Nasdaq: NGSX ) and Astellas ... Inc. announced today that the companies have entered into an exclusive Distribution, ...
... 22 Bringing the next level of technology ... eClinical solutions provider and subsidiary of PAREXEL International ... that it has launched its industry-leading eClinical Suite ... data across multiple technologies throughout the trial process. ...
... ... released by Esco. The videos can be viewed at: http://us.escoglobal.com/resources/hospital-pharmacy-products/videos.php . , ... Hatboro, PA (PRWEB) June ... and education videos for the compounding pharmacy industry. Titled "Pharmacy Isolator Safe ...
... To ... and Helen Sher, Founder of The Sher System, a drug-free therapy that has revolutionised the ... , ... -- Rosacea is a common skin condition that causes redness and swelling on the face. ...
... People with schizophrenia die from cancer four times as often ... of a new study published in the August 1, 2009 ... American Cancer Society. The study,s results suggest that extra efforts ... in patients with schizophrenia. Schizophrenia is associated with an ...
... recipients to suppress their immune systems, has a paradoxical effect ... Vaccine Center have discovered. In experiments conducted in both ... CD8 T cells, which enable the immune system to respond ... encounter. The results were published online ahead of print ...
Cached Medicine News:Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 2Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 3Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 4Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 5Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 6Health News:Perceptive Informatics Launches the Next Level of Integration in its Industry-Leading eClinical Suite 2Health News:Perceptive Informatics Launches the Next Level of Integration in its Industry-Leading eClinical Suite 3Health News:Perceptive Informatics Launches the Next Level of Integration in its Industry-Leading eClinical Suite 4Health News:Perceptive Informatics Launches the Next Level of Integration in its Industry-Leading eClinical Suite 5Health News:New Compounding Pharmacy Videos Provide Product Information, Teach Safety 2Health News:New Compounding Pharmacy Videos Provide Product Information, Teach Safety 3Health News:Helen Sher Launches Her Rosacea Awareness Campaign 2009 to Help Sufferers of this Distressing Condition 2Health News:Study finds cancer is the second most frequent cause of death in individuals with schizophrenia 2Health News:Transplant drug stimulates immune memory 2
(Date:7/28/2015)... , July 28, 2015 Dipexium ... pharmaceutical company focused on the development and commercialization ... new Locilex® microbiology data will be presented at ... Antimicrobial Agents and Chemotherapy and International Society of ... 2015) scientific meeting in San Diego, ...
(Date:7/28/2015)... 28, 2015 Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... underwritten public offering of 6,666,667 shares of its ... $11.25 per share. The gross proceeds to Egalet ... $75 million, before deducting the underwriting discounts and ...
(Date:7/28/2015)... 28, 2015  ULURU Inc. (OTCQB: ULUR) announced today the ... appointment of Bradley J. Sacks to the Company,s ... Directors has determined that the 2015 Annual Meeting of the ... 10:00 a.m., Central Daylight Time at the offices of ULURU ... 75001. In accordance with the provisions of the ...
Breaking Medicine Technology:Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3Egalet Announces Pricing of Public Offering of Common Stock 2Egalet Announces Pricing of Public Offering of Common Stock 3Egalet Announces Pricing of Public Offering of Common Stock 4ULURU Inc. Announces The Schedule For The 2015 Annual Meeting Of Stockholders And The Appointment Of Bradley J. Sacks To The Board Of Directors 2ULURU Inc. Announces The Schedule For The 2015 Annual Meeting Of Stockholders And The Appointment Of Bradley J. Sacks To The Board Of Directors 3
... 3 Herbruck Alder, a Cleveland -based employee benefits firm, will ... new federal healthcare reform law at a special forum on Thursday, August ... , , ... takes place from 8:30 a.m. to 1:30 p.m. , are human resources ...
... Mass. , Aug. 3 Instrumentation Laboratory (IL) today ... European CE IVD Mark product under the European Directive on In ... assay detects total immunoglobulin against Platelet Factor 4-Heparin complexes, the antibodies ... , , ...
Cached Medicine Technology:Herbruck Alder to Convene Summit on the New Healthcare Reform Law 2Instrumentation Laboratory Introduces Fully Automated, Liquid, Ready-to-Use HemosIL® HIT-Ab(PF4-H) Assay in Europe 2Instrumentation Laboratory Introduces Fully Automated, Liquid, Ready-to-Use HemosIL® HIT-Ab(PF4-H) Assay in Europe 3
... , The new Finnpipette Novus is so user-friendly that ... few minutes. With the intuitive instantly familiar menu and ... functions you need quickly and easily. The large, clear ... names of all functions. The easily accessible two ...
... Transfer an Entire Column of a 384 ... and throughput with 384 well plates, you need ... well spacing. Thats exactly what you get with ... Impact2 software (see Impact/Impact2), this innovation was specifically ...
... The Seal-Away CS and Alliance ... designed for the introduction of ... coronary sinus from a superior ... Jude Medical's outstanding peel-away introducer ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
Medicine Products: